TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 171 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,885,944 | +0.7% | 83,857 | -5.8% | 0.04% | +37.5% |
| Q4 2022 | $1,872,238 | +44.2% | 89,027 | +69.1% | 0.03% | +45.5% |
| Q3 2022 | $1,298,000 | -25.4% | 52,659 | -22.0% | 0.02% | -35.3% |
| Q1 2022 | $1,739,000 | -14.6% | 67,488 | +2.9% | 0.03% | -35.8% |
| Q4 2021 | $2,036,000 | +28.0% | 65,588 | 0.0% | 0.05% | +82.8% |
| Q3 2021 | $1,591,000 | – | 65,588 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |